Self-Efficacy and the Impact of Inflammatory Bowel Disease on Patients' Daily Lives

Self-efficacy, i.e., the confidence in one's capacity to perform a behavior, is crucial to the development of inflammatory bowel disease (IBD) self-management skills. We aimed to measure IBD self-efficacy and the relationship between self-efficacy and the patient-reported impact of IBD on daily...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheehan, Jessica L., Greene-Higgs, LaVana, Swanson, Linnea, Higgins, Peter D.R., Krein, Sarah L., Waljee, Akbar K., Saini, Sameer D., Berinstein, Jeffrey A., Mellinger, Jessica L., Piette, John D., Resnicow, Ken, Cohen-Mekelburg, Shirley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299768/
https://www.ncbi.nlm.nih.gov/pubmed/36881812
http://dx.doi.org/10.14309/ctg.0000000000000577
_version_ 1785064442621329408
author Sheehan, Jessica L.
Greene-Higgs, LaVana
Swanson, Linnea
Higgins, Peter D.R.
Krein, Sarah L.
Waljee, Akbar K.
Saini, Sameer D.
Berinstein, Jeffrey A.
Mellinger, Jessica L.
Piette, John D.
Resnicow, Ken
Cohen-Mekelburg, Shirley
author_facet Sheehan, Jessica L.
Greene-Higgs, LaVana
Swanson, Linnea
Higgins, Peter D.R.
Krein, Sarah L.
Waljee, Akbar K.
Saini, Sameer D.
Berinstein, Jeffrey A.
Mellinger, Jessica L.
Piette, John D.
Resnicow, Ken
Cohen-Mekelburg, Shirley
author_sort Sheehan, Jessica L.
collection PubMed
description Self-efficacy, i.e., the confidence in one's capacity to perform a behavior, is crucial to the development of inflammatory bowel disease (IBD) self-management skills. We aimed to measure IBD self-efficacy and the relationship between self-efficacy and the patient-reported impact of IBD on daily life. METHODS: We surveyed patients with IBD from a single academic center using the IBD Self-Efficacy Scale (IBD-SES) and patient-reported outcome (PRO) measures. The IBD-SES assesses 4 IBD domains: patients' confidence in managing stress and emotions, symptoms and disease, medical care, and remission. IBD PROs evaluate daily life impact, coping strategies, emotional impact, and systemic symptoms. We examined the association between IBD-SES domains with the lowest scores and IBD daily life impact. RESULTS: A total of 160 patients completed the survey. Domain scores on the IBD-SES were lowest for managing stress and emotions (mean 6.76, SD 1.86) and symptoms and disease (mean 6.71, SD 2.12) on a 1–10 scale. Controlling for age, sex, IBD type, disease activity, moderate-to-severe disease, depression and anxiety, a higher confidence in managing stress and emotions (β −0.12, 95% confidence interval −0.20 to −0.05, P = 0.001), and managing symptoms and disease (β −0.28, 95% confidence interval −0.35 to −0.20, P < 0.001) were each associated with lower IBD daily life impact. DISCUSSION: Patients with IBD report low confidence in managing stress and emotion and managing symptoms and disease. Higher self-efficacy in these domains was associated with lower IBD daily life impact. Self-management tools that promote self-efficacy in managing these domains have the potential to reduce IBD's daily life impact.
format Online
Article
Text
id pubmed-10299768
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-102997682023-06-28 Self-Efficacy and the Impact of Inflammatory Bowel Disease on Patients' Daily Lives Sheehan, Jessica L. Greene-Higgs, LaVana Swanson, Linnea Higgins, Peter D.R. Krein, Sarah L. Waljee, Akbar K. Saini, Sameer D. Berinstein, Jeffrey A. Mellinger, Jessica L. Piette, John D. Resnicow, Ken Cohen-Mekelburg, Shirley Clin Transl Gastroenterol Article Self-efficacy, i.e., the confidence in one's capacity to perform a behavior, is crucial to the development of inflammatory bowel disease (IBD) self-management skills. We aimed to measure IBD self-efficacy and the relationship between self-efficacy and the patient-reported impact of IBD on daily life. METHODS: We surveyed patients with IBD from a single academic center using the IBD Self-Efficacy Scale (IBD-SES) and patient-reported outcome (PRO) measures. The IBD-SES assesses 4 IBD domains: patients' confidence in managing stress and emotions, symptoms and disease, medical care, and remission. IBD PROs evaluate daily life impact, coping strategies, emotional impact, and systemic symptoms. We examined the association between IBD-SES domains with the lowest scores and IBD daily life impact. RESULTS: A total of 160 patients completed the survey. Domain scores on the IBD-SES were lowest for managing stress and emotions (mean 6.76, SD 1.86) and symptoms and disease (mean 6.71, SD 2.12) on a 1–10 scale. Controlling for age, sex, IBD type, disease activity, moderate-to-severe disease, depression and anxiety, a higher confidence in managing stress and emotions (β −0.12, 95% confidence interval −0.20 to −0.05, P = 0.001), and managing symptoms and disease (β −0.28, 95% confidence interval −0.35 to −0.20, P < 0.001) were each associated with lower IBD daily life impact. DISCUSSION: Patients with IBD report low confidence in managing stress and emotion and managing symptoms and disease. Higher self-efficacy in these domains was associated with lower IBD daily life impact. Self-management tools that promote self-efficacy in managing these domains have the potential to reduce IBD's daily life impact. Wolters Kluwer 2023-03-07 /pmc/articles/PMC10299768/ /pubmed/36881812 http://dx.doi.org/10.14309/ctg.0000000000000577 Text en © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Article
Sheehan, Jessica L.
Greene-Higgs, LaVana
Swanson, Linnea
Higgins, Peter D.R.
Krein, Sarah L.
Waljee, Akbar K.
Saini, Sameer D.
Berinstein, Jeffrey A.
Mellinger, Jessica L.
Piette, John D.
Resnicow, Ken
Cohen-Mekelburg, Shirley
Self-Efficacy and the Impact of Inflammatory Bowel Disease on Patients' Daily Lives
title Self-Efficacy and the Impact of Inflammatory Bowel Disease on Patients' Daily Lives
title_full Self-Efficacy and the Impact of Inflammatory Bowel Disease on Patients' Daily Lives
title_fullStr Self-Efficacy and the Impact of Inflammatory Bowel Disease on Patients' Daily Lives
title_full_unstemmed Self-Efficacy and the Impact of Inflammatory Bowel Disease on Patients' Daily Lives
title_short Self-Efficacy and the Impact of Inflammatory Bowel Disease on Patients' Daily Lives
title_sort self-efficacy and the impact of inflammatory bowel disease on patients' daily lives
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299768/
https://www.ncbi.nlm.nih.gov/pubmed/36881812
http://dx.doi.org/10.14309/ctg.0000000000000577
work_keys_str_mv AT sheehanjessical selfefficacyandtheimpactofinflammatoryboweldiseaseonpatientsdailylives
AT greenehiggslavana selfefficacyandtheimpactofinflammatoryboweldiseaseonpatientsdailylives
AT swansonlinnea selfefficacyandtheimpactofinflammatoryboweldiseaseonpatientsdailylives
AT higginspeterdr selfefficacyandtheimpactofinflammatoryboweldiseaseonpatientsdailylives
AT kreinsarahl selfefficacyandtheimpactofinflammatoryboweldiseaseonpatientsdailylives
AT waljeeakbark selfefficacyandtheimpactofinflammatoryboweldiseaseonpatientsdailylives
AT sainisameerd selfefficacyandtheimpactofinflammatoryboweldiseaseonpatientsdailylives
AT berinsteinjeffreya selfefficacyandtheimpactofinflammatoryboweldiseaseonpatientsdailylives
AT mellingerjessical selfefficacyandtheimpactofinflammatoryboweldiseaseonpatientsdailylives
AT piettejohnd selfefficacyandtheimpactofinflammatoryboweldiseaseonpatientsdailylives
AT resnicowken selfefficacyandtheimpactofinflammatoryboweldiseaseonpatientsdailylives
AT cohenmekelburgshirley selfefficacyandtheimpactofinflammatoryboweldiseaseonpatientsdailylives